Genenta Science SpA EBIT

Genenta Science SpA (GNTA) currently reports a EBIT of $-16M as of December 2025. That compares with $-12M in the prior-year period — down 41.2% year over year. That is above the sector sector average of $-63M. Use the charts on this page to explore Genenta Science SpA's EBIT history and peer comparisons.

Genenta Science SpA's EBIT decreased from $-12M to $-16M — a 41.2% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Genenta Science SpA's EBIT of $-16M is higher than the its sector sector average of $-63M. That is roughly 73.9% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Genenta Science SpA reported $-16M in EBIT as of December 2025. That compares with $-12M in the prior-year period — down 41.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-16M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $-63M. From there, open related valuation or income-statement pages for Genenta Science SpA, and consider following GNTA for alerts when major investors trade the stock.